OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder

By McBurnett Keith   Starr H Lynn  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 315-324

Informa Healthcare

Access to resources Recommend Favorite

Attention deficit hyperactivity disorder pharmacogenetics: the dopamine transporter and D4 receptor

By McGough James J  

Pharmacogenomics, Vol. 13, Iss. 4, 2012-03 ,pp. : 365-368

Future Medicine

Access to resources Recommend Favorite

An Exploration of Site Effects in a Multisite Trial of OROS-Methylphenidate for Smokers with Attention Deficit/Hyperactivity Disorder

By Covey Lirio S.   Hu Mei-Chen   Green Carla A.   Brigham Gregory   Hurt Richard D.   Adler Lenard   Winhusen Theresa  

The American Journal of Drug and Alcohol Abuse, Vol. 37, Iss. 5, 2011-09 ,pp. : 392-399

Informa Healthcare

Access to resources Recommend Favorite

Methylphenidate improves response inhibition but not reflection–impulsivity in children with attention deficit hyperactivity disorder (ADHD)

By DeVito Elise   Blackwell Andrew   Clark Luke   Kent Lindsey   Dezsery Anna   Turner Danielle   Aitken Michael   Sahakian Barbara  

Psychopharmacology, Vol. 202, Iss. 1-3, 2009-01 ,pp. : 531-539

Springer Publishing Company

Access to resources Recommend Favorite

Methylphenidate Transdermal System: In Attention-Deficit Hyperactivity Disorder in Adolescents

By Keating Gillian M.  

CNS Drugs, Vol. 25, Iss. 4, 2011-04 ,pp. : 333-342

Adis International

Access to resources Recommend Favorite